Skip Navigation

Advertise|Press|Contact|FAQ|About Us

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Rheumatology | Musculoskeletal | Immunology | Family Medicine
Disease Category: Rheumatoid Arthritis
Location: United States, NJ

Clinical Trial Details

Overview

Research Study Summary

A multi-center, randomized, blinded, parallel-group study of the reduction of signs and symptoms during monotherapy treatment with tocilizumab 8 mg/kg intravenously versus adalimumab 40 mg subcutaneously in patients with rheumatoid arthritis

Purpose

A multi-center, randomized, blinded, parallel-group study of the reduction of signs and symptoms during monotherapy treatment with tocilizumab 8 mg/kg intravenously versus adalimumab 40 mg subcutaneously in patients with rheumatoid arthritis

Patient Inclusion Criteria:

  • Able and willing to give written informed consent and comply with requirements of the study protocol.
  • RA patients who never used biologic medications.
  • RA patients who are on Methotrexate or used it in the past.

Patient Exclusion Criteria:

  • Current or previous evidence of serious uncontrolled cardiovascular, nervous system, pulmonary, renal, hepatic, endocrine or gastrointestinal disease.

To Learn more
Phase

3

Gender

Both Male and Female

Age

N/A

Overall Status

Recruiting

Facility Type

N/A

Contact

Fay Chen RN, Clinical Research Coordinator
Rutgers, The State University of New Jersey - Robert Wood Johnson Medical School
Clinical Research Center Acute Care Building, 3rd floor 51 French Street
New Brunswick, NJ 08903
Phone: 732-418-8484
Fax: 732-418-8480

View Map

If you would like to learn more about participating in this research study, please email the trial contact using the form below.

Name:
Address:
City:
State:
Zip/Postal Code:
Country:
Phone:
Email:  
Message:
 
Please leave this field empty.

CW ID: 166473

Date Last Changed: July 23, 2013


DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.